Dr. James J. Brown, M.D.
Retina Specialist (Retina Specialist (Ophthalmology) Physician)
- Medicare participating
At a glance
- Medical school
- University of Mississippi School of Medicine (2006)
- Years since graduation
- 20
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,751
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Medical school: University of Mississippi School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Retina Specialist (Ophthalmology) Physician primary
MS license 18420 -
Ophthalmology Physician
MS license 18420
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mississippi Baptist Medical Center Jackson, MS
- Merit Health River Oaks Flowood, MS
- King's Daughters Medical Center-Brookhaven Brookhaven, MS
Medical groups
- Mississippi Retina Associates,pllc (7 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,751
- Services billed
- 22,586
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Injection, aflibercept, 1 mg | 6,441 | 736 |
| Imaging of retina | 5,248 | 2,140 |
| Injection of drug into eye | 3,538 | 962 |
| Established patient office or other outpatient visit, 20-29 minutes | 2,120 | 1,489 |
| Injection, faricimab-svoa, 0.1 mg | 1,621 | 11 |
| Injection, ranibizumab, 0.1 mg | 840 | 44 |
| Compounded drug, not otherwise classified | 703 | 205 |
| New patient office or other outpatient visit, 30-44 minutes | 368 | 368 |
| Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 215 | 20 |
| New patient office or other outpatient visit, 45-59 minutes | 119 | 119 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Prednisolone Acetate Other prescribers in Jackson, MS | 358 |
| Latanoprost Other prescribers in Jackson, MS | 257 |
| Ofloxacin Other prescribers in Jackson, MS | 100 |
| Brimonidine Tartrate Other prescribers in Jackson, MS | 63 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Jackson, MS | 47 |
| Timolol Maleate Other prescribers in Jackson, MS | 42 |
| Combigan (brimonidine tartrate/timolol) Other prescribers in Jackson, MS | 42 |
| Dorzolamide Hcl Other prescribers in Jackson, MS | 26 |
| Brimonidine Tartrate-Timolol (brimonidine tartrate/timolol) Other prescribers in Jackson, MS | 20 |
| Simbrinza (brinzolamide/brimonidine tart) Other prescribers in Jackson, MS | 15 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 13 payments worth $413 in total to this clinician.
| AbbVie Inc. | $183 |
|---|---|
| Regeneron Healthcare Solutions, Inc. | $87.52 |
| Astellas Pharma US Inc | $64.13 |
| Neurotech Pharmaceuticals, Inc. | $29.49 |
| Rxsight Inc | $27.78 |
| Ocular Therapeutix, Inc. | $20.44 |
| Food and Beverage | $385 |
|---|---|
| Honoraria | $27.78 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Rxsight Inc Aug 26, 2025 | Honoraria RXSIGHT CONTACT LENS; RXSIGHT INJECTOR CARTRIDGE; LIGHT ADJUSTABLE LENS (LAL) · OPHTHALMOLOGY · in-kind | $27.78 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.